Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129969560> ?p ?o ?g. }
- W3129969560 abstract "Good-quality evidence has shown that early glycaemic, blood pressure and LDL-cholesterol control in people with type 2 diabetes (T2D) leads to better outcomes. In spite of that, diseases control have been inadequate globally, and therapeutic inertia could be one of the main cause. Evidence on therapeutic inertia has been lacking at primary care setting. This retrospective cohort study aimed to determine the proportions of therapeutic inertia when treatment targets of HbA1c, blood pressure and LDL-cholesterol were not achieved in adults with T2D at three public health clinics in Malaysia.The index prescriptions were those that when the annual blood tests were reviewed. Prescriptions of medication were verified, compared to the preceding prescriptions and classified as 1) no change, 2) stepping up and 3) stepping down. The treatment targets were HbA1c < 7.0% (53 mmol/mol), blood pressure (BP) < 140/90 mmHg and LDL-cholesterol < 2.6 mmol/L. Therapeutic inertia was defined as no change in the medication use in the present of not reaching the treatment targets. Descriptive, univariable, multivariable logistic regression and sensitive analyses were conducted.A total of 552 cohorts were available for the assessment of therapeutic inertia (78.9% completion rate). The mean (SD) age and diabetes duration were 60.0 (9.9) years and 5.0 (6.0) years, respectively. High therapeutic inertia were observed in oral anti-diabetic (61-72%), anti-hypertensive (34-65%) and lipid-lowering therapies (56-77%), and lesser in insulin (34-52%). Insulin therapeutic inertia was more likely among those with shorter diabetes duration (adjusted OR 0.9, 95% CI 0.87, 0.98). Those who did not achieve treatment targets were less likely to experience therapeutic inertia: HbA1c ≥ 7.0%: adjusted OR 0.10 (0.04, 0.24); BP ≥ 140/90 mmHg: 0.28 (0.16, 0.50); LDL-cholesterol ≥ 2.6 mmol/L: 0.37 (0.22, 0.64).Although therapeutic intensifications were more likely in the presence of non-achieved treatment targets but the proportions of therapeutic inertia were high. Possible causes of therapeutic inertia were less of the physician behaviours but might be more of patient-related non-adherence or non-availability of the oral medications. These observations require urgent identification and rectification to improve disease control, avoiding detrimental health implications and costly consequences.Number NCT02730754 , April 6, 2016." @default.
- W3129969560 created "2021-03-01" @default.
- W3129969560 creator A5017382936 @default.
- W3129969560 creator A5039998375 @default.
- W3129969560 creator A5059475074 @default.
- W3129969560 date "2021-06-11" @default.
- W3129969560 modified "2023-09-27" @default.
- W3129969560 title "Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study" @default.
- W3129969560 cites W1525863247 @default.
- W3129969560 cites W1911896121 @default.
- W3129969560 cites W1983269691 @default.
- W3129969560 cites W2023233725 @default.
- W3129969560 cites W2026068973 @default.
- W3129969560 cites W2060109662 @default.
- W3129969560 cites W2085413459 @default.
- W3129969560 cites W2099468119 @default.
- W3129969560 cites W2105744242 @default.
- W3129969560 cites W2110020655 @default.
- W3129969560 cites W2128483120 @default.
- W3129969560 cites W2156990409 @default.
- W3129969560 cites W2165825148 @default.
- W3129969560 cites W2204221403 @default.
- W3129969560 cites W2309993990 @default.
- W3129969560 cites W2415631415 @default.
- W3129969560 cites W2497702485 @default.
- W3129969560 cites W2505230369 @default.
- W3129969560 cites W2543290707 @default.
- W3129969560 cites W2591123231 @default.
- W3129969560 cites W2626675868 @default.
- W3129969560 cites W2738595939 @default.
- W3129969560 cites W2743048109 @default.
- W3129969560 cites W2745170751 @default.
- W3129969560 cites W2748858803 @default.
- W3129969560 cites W2754058741 @default.
- W3129969560 cites W2754068992 @default.
- W3129969560 cites W2766738474 @default.
- W3129969560 cites W2783010843 @default.
- W3129969560 cites W2801806897 @default.
- W3129969560 cites W2809612008 @default.
- W3129969560 cites W2883780483 @default.
- W3129969560 cites W2899009485 @default.
- W3129969560 cites W2915527669 @default.
- W3129969560 cites W2943649752 @default.
- W3129969560 cites W3005573419 @default.
- W3129969560 cites W3022066539 @default.
- W3129969560 cites W3046870216 @default.
- W3129969560 cites W3092248866 @default.
- W3129969560 cites W4253539425 @default.
- W3129969560 cites W4255037836 @default.
- W3129969560 doi "https://doi.org/10.1186/s12875-021-01472-2" @default.
- W3129969560 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8194183" @default.
- W3129969560 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34116645" @default.
- W3129969560 hasPublicationYear "2021" @default.
- W3129969560 type Work @default.
- W3129969560 sameAs 3129969560 @default.
- W3129969560 citedByCount "5" @default.
- W3129969560 countsByYear W31299695602022 @default.
- W3129969560 countsByYear W31299695602023 @default.
- W3129969560 crossrefType "journal-article" @default.
- W3129969560 hasAuthorship W3129969560A5017382936 @default.
- W3129969560 hasAuthorship W3129969560A5039998375 @default.
- W3129969560 hasAuthorship W3129969560A5059475074 @default.
- W3129969560 hasBestOaLocation W31299695601 @default.
- W3129969560 hasConcept C102652120 @default.
- W3129969560 hasConcept C126322002 @default.
- W3129969560 hasConcept C134018914 @default.
- W3129969560 hasConcept C151956035 @default.
- W3129969560 hasConcept C167135981 @default.
- W3129969560 hasConcept C1862650 @default.
- W3129969560 hasConcept C201903717 @default.
- W3129969560 hasConcept C2426938 @default.
- W3129969560 hasConcept C2776217022 @default.
- W3129969560 hasConcept C2777180221 @default.
- W3129969560 hasConcept C2780221984 @default.
- W3129969560 hasConcept C555293320 @default.
- W3129969560 hasConcept C71924100 @default.
- W3129969560 hasConcept C72563966 @default.
- W3129969560 hasConcept C84393581 @default.
- W3129969560 hasConcept C98274493 @default.
- W3129969560 hasConceptScore W3129969560C102652120 @default.
- W3129969560 hasConceptScore W3129969560C126322002 @default.
- W3129969560 hasConceptScore W3129969560C134018914 @default.
- W3129969560 hasConceptScore W3129969560C151956035 @default.
- W3129969560 hasConceptScore W3129969560C167135981 @default.
- W3129969560 hasConceptScore W3129969560C1862650 @default.
- W3129969560 hasConceptScore W3129969560C201903717 @default.
- W3129969560 hasConceptScore W3129969560C2426938 @default.
- W3129969560 hasConceptScore W3129969560C2776217022 @default.
- W3129969560 hasConceptScore W3129969560C2777180221 @default.
- W3129969560 hasConceptScore W3129969560C2780221984 @default.
- W3129969560 hasConceptScore W3129969560C555293320 @default.
- W3129969560 hasConceptScore W3129969560C71924100 @default.
- W3129969560 hasConceptScore W3129969560C72563966 @default.
- W3129969560 hasConceptScore W3129969560C84393581 @default.
- W3129969560 hasConceptScore W3129969560C98274493 @default.
- W3129969560 hasIssue "1" @default.
- W3129969560 hasLocation W31299695601 @default.
- W3129969560 hasLocation W31299695602 @default.
- W3129969560 hasLocation W31299695603 @default.
- W3129969560 hasLocation W31299695604 @default.